Michael Scordo, MD^1,2, Geoffrey Shouse, PhD, DO³, Luke Mountjoy, DO⁴, Jordan Gauthier, MD^5,6, Bhagirathbhai Dholaria, MBBS^7,8, Scott D. Rowley, MD⁹, Jeremy M. Pantin, MD, FACP¹⁰, Zachariah Defilipp, MD¹¹, Monica Mead, MD, BS¹² and Paul Finnegan, MD¹³

¹Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
²Department of Medicine, Weill Cornell Medical College, New York, NY
³Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁴Hematology Department, Colorado Blood Cancer Institute, Denver, CO
⁵Fred Hutchinson Cancer Research Center, Seattle, WA, USA, Seattle, WA
⁶Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
⁷Division of Hematology/Oncology, Department of Medicine, Vanderbilt School of Medicine, Nashville, TN
⁸Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
⁹Stem Cell Transplantation and Cellular Therapy Program, Hackensack University Medical Center, John Theurer Cancer Center, Hackensack, NJ
¹⁰Department of Hematopoietic Cell Therapy, Sarah Cannon Center for Blood Cancer at TriStar Centennial Medical Center, Nashville, TN
¹¹Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, MA
¹²Department of Medicine, Division of Hematology/Oncology, UCLA Medical Center, Santa Monica, CA
¹³Angiocrine Bioscience, San Diego, CA

Leona A Holmberg, MD, PhD^1,2, Damian J. Green, MD^1,3, Sarah S Lee, MD^1,2 and Andrew J Cowan, MD^1,2

¹Division of Medical Oncology, Department of Medicine, University of Washington, Seattle, WA
²Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
³Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA

Luis F. Porrata, MD¹, David J. Inwards, MD², Stephen M. Ansell, MD, PhD¹, Ivana N. Micallef, MD¹, Patrick B. Johnston, MD, PhD³, Jose C. Villasboas, MD¹, Jonas Paludo, MD², Urshila Durani, MD, MPH³ and Svetomir N. Markovic, MD, PhD⁴

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Division of Hematology, Department of Medicine, Mayo Clinic, Rochester, MN
³Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN
⁴Division of Medical Oncology, Mayo Clinic, Rochester, MN

Yetunde Ogunsesan, MD^1*, Reid D. Landes, PhD^2*, Jaskirat Sethi, MD^1*, Munawwar Hussain, MD^1*, Nishanth Thalambedu, MD^1*, Lakshmi Yarlagadda, MD^1*, Sravani Gundarlapalli, MD^1*, Clyde Bailey^1*, Samer Al Hadidi, MD, MSc¹, Sharmilan Thanendrarajan, MD¹, Maurizio Zangari, MD¹, John D. Shaughnessy Jr., PhD^1*, Fenghuang Zhan, MD, PhD¹, Frits van Rhee¹ and Carolina Schinke¹

¹Myeloma Center, University of Arkansas for Medical Sciences, Little Rock, AR
²Department of Biostatistics, University of Arkansas for Medical Sciences, Little Rock, AR

Robert Puckrin, MD¹, Russell Sterrett, MD^2*, Neil Chua, MD^2*, Carolyn Owen, MD¹, Peter Duggan, MD, FRCPC¹, Mona Shafey, MD¹ and Douglas A. Stewart, MD³

¹Tom Baker Cancer Centre, University of Calgary, Calgary, AB, Canada
²Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada
³Tom Baker Cancer Centre, Tom Baker Cancer Centre, Calgary, AB, Canada

Hussein Awada^1*, Adel Hajj Ali, MD^2*, Danai Dima, MD¹, Lauren M. Granat, DO, MS^3*, Michael Sheu, MD^3*, Puneet Dhillon, DO^3*, Mikhaila Rice, PharmD^4*, Heena P Kurish, PharmD^4*, Louis S. Williams, MD⁵, Faiz Anwer, MD⁵ and Jack Khouri, MD⁵

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
²Heart, Vascular & Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH
³Department of Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH
⁴Department of Pharmacy, Cleveland Clinic, Cleveland, OH
⁵Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Huimin Liu^1*, Hesong Zou^1*, Wei Liu^2*, Wenyang Huang, MD^1*, Shuhui Deng, MD^1*, Rui Lv^1*, Weiwei Sui^1*, Yan Xu^1*, Shuhua Yi, MD^1*, Tingyu Wang^2*, Mingwei Fu, MD^1*, Gang An, MD^3*, Yaozhong Zhao^1*, Lugui Qiu¹ and Dehui Zou^1*

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences &Peking Union Medical College, Tianjin, China
²State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical Colleg, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Jayanshu Jain, MD^1*, Ghena Khasawneh, MBBS^2*, Hamza Hashmi, MD^3,4, Meera Mohan, MD^4,5, Zahra Mahmoudjafari, PhD^4,6*, Wei Cui, MD^4,7*, Joseph P. McGuirk, DO⁶, Leyla O. Shune, MD^8,9, Nausheen Ahmed, MD^4,10, Al-Ola Abdallah, MD^8,11 and Shebli Atrash, MD^4,12

¹Division of Hematology/Oncology, University of Kansas Medical Center, Kansas city, KS
²Faculty of Medicine, Jordan University of Science and Technology, Irbid, JOR
³Department of Hematology/Medical Oncology, Medical University of South Carolina, Charleston, SC
⁴US Myeloma Research Innovations Research Collaborative (USMIRC), Westwood, KS
⁵Medical College of Wisconsin, Milwaukee, WI
⁶Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
⁷University of Kansas Medical Center, Kansas City, KS
⁸US Myeloma Innovations Research Collaborative (USMIRC), Westwood, KS
⁹The University of Kansas Medical Center, Kansas City, KS
¹⁰Division of Hematologic Malignancies & Cellular Therapeutics, The University of Kansas Cancer Center, Westwood, KS
¹¹Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
¹²Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, NC

Oren Pasvolsky, MD^1,2,3*, Denái R Milton, MS^4*, Adeel Masood^1*, Sophiya S Shehzad^1*, Mark R Tanner, PhD^1*, Qaiser Bashir, MD¹, Samer A Srour, MD, MS¹, Neeraj Saini, MD¹, Jeremy L. Ramdial, MD¹, Yago Nieto, MD¹, Hans C. Lee, MD⁵, Krina Patel, MD, MSc⁵, Partow Kebriaei, MD¹, Sheeba K Thomas, MD⁵, Donna M. Weber, MD⁵, Robert Z. Orlowski, MD, PhD⁵, Elizabeth J Shpall, MD¹, Richard E Champlin, MD¹ and Muzaffar H Qazilbash, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
³Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Hussein Awada^1*, Adel Hajj Ali, MD^2*, Muhammad Faizan Ali, MD^3*, Sandra Mazzoni, DO^4*, Beth M. Faiman, PhD, CNP⁴, Deepa Jagadeesh, MD⁴, Louis S. Williams, MD⁴, Allison Winter, MD⁴, Christy J. Samaras, DO⁴, Craig S. Sauter, MD^5*, Willem J. van Heeckeren, MD, PhD⁴, Robert M. Dean, MD⁴, Brad Pohlman, MD⁴, Brian T. Hill, MD, PhD⁴, Jason Valent, MD⁴, Ronald M. Sobecks, MD⁴, Betty K. Hamilton, MD⁶, Matt Kalaycio, MD⁴, Faiz Anwer, MD⁴ and Jack Khouri, MD⁴

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
²Heart, Vascular & Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH
³Department of Internal Medicine, Cleveland Clinic Akron General Hospital, Cleveland, OH
⁴Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
⁵Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland Clinic, Cleveland, OH
⁶Cleveland Clinic Foundation, Cleveland, OH

Saad Akhtar, MD^1*, M Shahzad Rauf, MD^2*, Tusneem Elhassan, MSc^3*, Z A Khan, MD^4*, Mahmoud Elshenawy^5* and Irfan Maghfoor, MD^6*

¹Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Riyadh, Saudi Arabia
²Oncology Center, King Faisal Specialist Hospital and Research Centre, RIYADH, RIYADH, Saudi Arabia
³Oncology Center, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
⁴Nuclear Medicine Radiology Department, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia
⁵King Faisal Specialist Hospital and Research Center,, Riyadh, SAU
⁶Oncology Center, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia

Hussein Awada^1*, Adel Hajj Ali, MD^2*, Beth M. Faiman, PhD, CNP³, Allison Winter, MD³, Sandra Mazzoni, DO^3*, Christy J. Samaras, DO³, Craig S. Sauter, MD^4*, Willem J. van Heeckeren, MD, PhD³, Robert M. Dean, MD³, Brad Pohlman, MD³, Brian T. Hill, MD, PhD³, Jason Valent, MD³, Ronald M. Sobecks, MD³, Louis S. Williams, MD³, Deepa Jagadeesh, MD³, Betty K. Hamilton, MD⁵, Matt Kalaycio, MD³, Faiz Anwer, MD³ and Jack Khouri, MD³

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
²Heart, Vascular & Thoracic Institute, Cleveland Clinic Foundation, Cleveland, OH
³Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
⁴Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland Clinic, Cleveland, OH
⁵Cleveland Clinic Foundation, Cleveland, OH